Price
3,352.8
+0.95%52W Range
Market Cap
₹7,721.71 Cr
Traded: ₹5.98 Cr (0.08%) 0.0x
Free Float: ₹991.47 Cr (0.60% of FF traded)
Volume · 60D trend
17.86 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | -- | -- | +1.0% | -- |
| ROE | -- | -- | -- | -- | -- | -- |
| Return | +2.0% | -8.0% | -10.0% | -48.0% | -- | Decelerating |
| Profit | -- | -- | -- | -- | -25.0% | -- |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|
| Sales | 515 | 524 | 464 | 511 | 469 | 491 | 515 |
| Expenses | 397 | 404 | 348 | 374 | 370 | 377 | 393 |
| Operating Profit | 118 | 120 | 116 | 137 | 100 | 114 | 122 |
| OPM % | 23.0% | 23.0% | 25.0% | 27.0% | 21.0% | 23.0% | 24.0% |
| Other Income | 14 | 2 | 21 | 41 | 77 | 82 | 57 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 10 | 9 | 9 | 9 | 9 | 9 | 9 |
| Profit Before Tax | 122 | 113 | 127 | 169 | 167 | 186 | 169 |
| Tax % | 25.0% | 27.0% | 19.0% | 19.0% | 18.0% | 18.0% | 27.0% |
| Net Profit | 91 | 82 | 103 | 137 | 138 | 152 | 123 |
| Exceptional Items | 8 | 0 | 16 | 38 | 68 | 71 | 42 |
| EPS (Rs) | 39.7 | 35.7 | 44.9 | 59.4 | 59.9 | 66.0 | 53.4 |
| Sales Growth (YoY) | 9.7% | 6.8% | -10.0% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -1.7% | 12.9% | -9.2% | 9.0% | -4.5% | -4.7% | -- |
| OP Growth (YoY) | 18.0% | 5.3% | -4.9% | -- | -- | -- | -- |
| OP Growth (QoQ) | -1.7% | 3.4% | -15.3% | 37.0% | -12.3% | -6.6% | -- |
| Profit Growth (YoY) | 22.0% | 2.0% | 15.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | -33.7% | -45.9% | -16.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 11.1% | -20.4% | -24.4% | -0.8% | -9.3% | 23.6% | -- |
| OP Margin | 22.9% | 22.9% | 25.0% | 26.8% | 21.3% | 23.2% | 23.7% |
| Net Margin | 17.7% | 15.7% | 22.2% | 26.8% | 29.4% | 31.0% | 23.9% |
| Material Cost % | 48.5% | 49.6% | 47.7% | 48.6% | 46.8% | 48.7% | 49.8% |
| Employee Cost % | 10.4% | 10.8% | 13.0% | 13.6% | 15.4% | 14.6% | 13.6% |
| P/S | 3.83 | -- | -- | -- | -- | -- | -- |
| P/E | 18.66 | -- | -- | -- | -- | -- | -- |
| P/B | 8.97 | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Kindly refer the attachment
Kindly refer the attachment
Kindly refer the attachment.
Kindly refer the attachment
Kindly refer the attachment
Kindly refer the attachment
Kindly refer the attachment
Kindly refer the attachment
Kindly refer the attachment
Kindly refer the attachment.
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
Please find enclosed certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2026.
Please find enclosed disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Kindly refer the attachment
Please find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Please find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Please find enclosed copies of the Newspaper publication regarding the information on special window for transfer and dematerialisation of physical shares.
Please find enclosed Press Release dated 30th April 2026
Please find enclosed copies of the Newspaper Publication of Financial Results for quarter ended 31st March 2026, as published in Business Standard (English) and Sakal (Marathi) today i.e. ....
Please find enclosed proceedings of 70th Annual General Meeting.
Please find enclosed Scrutinizers Report on 70th Annual General Meeting.
Please find enclosed a copy of Unaudited Financial Results for the quarter ended 31st March 2026
Press Release dated 28th April 2026 enclosed.
Please find enclosed a copy of the Unaudited Financial Results for the Quarter ended 31st March 2026
Kindly refer the attachment.
Kindy refer the attachment
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited), Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for ....
Please find enclosed copies of Newspaper publications.
Please refer the attachment
Please refer the attachment
Please refer the attachment
Please refer the attachment
Please refer the attachment
Please refer the attachment
Please find enclosed Newspaper Advertisement regarding 70th Annual General Meeting and Opening of another Special Window for re-lodgement of transfer requests of physical shares.
Please find enclosed intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Please refer the attachment
Please refer the attachment
Please refer the attachment
Please refer the attachment
We would like to inform you that pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the officials of the Company ....
Intimation for closure of Trading Window for the quarter ending 31st March 2026
Please find enclosed copies of newspaper advertisement regarding notice to the shareholders whose shares are liable to be transferred to the Investor Education and Protection Fund (IEPF) Authority.
Please find enclosed transcript of Investor/ Analysts call held on 26th February 2026
This is to inform you that the Audio-Video recording of the Investors/Analysts Call held on 26th February 2026 at 4:00pm for discussion on Financial Results for the quarter and year ended ....
Please find enclosed Annual Secretarial Compliance Report for the year ended 31st December 2025.
Please find enclosed copies of the Newspaper Publication of Financial Results for the quarter and year ended 31st December, 2025 of the Company published on 26th February 2026, in Business ....
Please find enclosed presentation that will be made at the investor call.
Annual Reports
15Concalls
12Mar 2026
31 Mar 2026Nov 2025
30 Nov 2025May 2024
31 May 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Nov 2023
30 Nov 2023May 2023
31 May 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Feb 2023
28 Feb 2023Mar 2021
31 Mar 2021Held by ETFs
1 ETFs hold sanofi · sorted by weight
Held by Mutual Funds
16 schemes hold sanofi · sorted by weight